SHC3 and neuroblastoma: It was shown to be constitutively activated by amplification at the ALK locus in neuroblastoma cell lines [26], and suppression of activated ALK in such cells induced apoptotic changes through reduction in the phosphorylation of ShcC, a Src homology 2 domain-containing adaptor molecule involved in signaling through the MAP kinase pathway.